First Allied Advisory Services’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

First Allied Advisory Services’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,821	Closed	-$895K	–	1188
2015 Q1	$895K	Buy	+1,821	New	+$706K	0.06%	382
2014 Q4	–	Sell	-1,206	Closed	-$231K	–	1111
2014 Q3	$231K	Buy	+1,206	New	+$265K	0.02%	853

Other funds holding LUMO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TAM

Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

First Allied Advisory Services's LUMO Position: Q2 2015 in Review

First Allied Advisory Services sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2015, closing a stake of 1,821 shares — an estimated $895K sold.

First Allied Advisory Services first reported a position in LUMO in Q3 2014 and held it in 2 quarters. The position peaked at $895K in Q1 2015. 145 funds tracked by Wall St. Rank hold LUMO as of Q2 2015.

First Allied Advisory Services reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
First Allied Advisory Services sold 1,821 Lumos Pharma, Inc. Common Stock shares in Q2 2015, an estimated $895K.
First Allied Advisory Services first reported a position in Lumos Pharma, Inc. Common Stock in Q3 2014 and held it in 2 quarters.
First Allied Advisory Services's Lumos Pharma, Inc. Common Stock position peaked at $895K in Q1 2015.
145 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2015.

Based on First Allied Advisory Services's 13F filing for Q2 2015, filed 13 Aug 2015.